Medikaloka Hermina Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Medikaloka Hermina Tbk. trades at Rp880 (market cap 13.68T, 286.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 23.2K 24h volume). The key difference: Medikaloka Hermina Tbk. is far larger — about 81.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Medikaloka Hermina Tbk. is more actively traded (286.9K versus 23.2K). Which is the better fit depends on your goals.
| HEAL | OBAT | |
|---|---|---|
Market Cap | 13.68T | 167.37B |
Volume | 286.9K | 23.2K |
Lot | 2.87K | 232 |
Turnover | 254.89M | 5.73M |
Average Price | 888.43 | 246.93 |
Value | 254.89M | 5.73M |
Indicative Equilibrium Price | 895 | 246 |
Indicative Equilibrium Volume | 201 | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Medikaloka Hermina Tbk (“the Company”) was established based on Notarial Deed of Imam Santoso, S.H., No. 5 dated May 7, 1999.
Read more on HEAL →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →